Avrio Biopharmaceuticals CEO and leadership

Dr. Alani, with almost 30 years of experience, has held senior leadership roles across global organizations including Alcon/Novartis, Merck, Abbott and Pfizer. She is co-inventor on over 40 patents and has helped lead more than 20 successful drug product launches over her career including both small and large molecules.

​

Examples of products Dr. Alani provided technical and managerial leadership for include Omiflex®, Norvir®, Kaletra®, Gengraf®, Biaxin® XL, Caduet®, Janumet®, Januvia™, Isentress™, Lyrica®, recombinant urokinase, Lupron® and brolucizumab.

​

Prior to LifeMax, Dr. Alani served as VP of Pharmaceutical Product/Technology Development at Alcon. Before that, she was with Impax heading up Product Development. Prior to Impax, she held leadership roles at Merck for both product development and creating/executing a multi-year business strategy in partnership with the President. Before that, she was with Pfizer focusing on late stage development and co-led a team to build a process for tech transfer between research and manufacturing.

​

Dr. Alani began her career at Abbott where she spent 10 years in different roles across businesses and was responsible for introducing new drug delivery technologies. She received her Ph.D. in Medicinal Chemistry from University of Kansas.